{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:47:12Z","timestamp":1648824432884},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.neurol.2009.01.049","type":"journal-article","created":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T08:35:35Z","timestamp":1238142935000},"page":"901-910","source":"Crossref","is-referenced-by-count":4,"title":["Myasth\u00e9nie s\u00e9ron\u00e9gative et myasth\u00e9nie avec anticorps anti-MuSK\u00a0: une s\u00e9rie r\u00e9trospective de 20 cas"],"prefix":"10.1016","volume":"165","author":[{"given":"S.","family":"Aubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Salort-Campana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Franques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Uzenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pouget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2009.01.049_bib1","first-page":"901","article-title":"Myasth\u00e9nie s\u00e9ron\u00e9gative et myasth\u00e9nie avec anticorps anti-MuSK\u00a0: une s\u00e9rie r\u00e9trospective de 20\u00a0cas","volume":"165","author":"Aubert","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.01.049_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jnnp.2006.093567","article-title":"Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis","volume":"78","author":"Baek","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.01.049_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/01.wnl.0000228225.23349.5d","article-title":"Anti-MuSK antibodies: correlation with myasthenia gravis severity","volume":"67","author":"Bartoccioni","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.01.049_bib4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.nmd.2007.03.007","article-title":"Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness","volume":"17","author":"Casasnovas","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2009.01.049_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bjo.2006.108498","article-title":"Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy","volume":"91","author":"Chan","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurol.2009.01.049_bib6","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/WNL.37.12.1854","article-title":"Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians","volume":"37","author":"Chiu","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.01.049_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/01.wnl.0000254620.45529.97","article-title":"Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis","volume":"68","author":"Deymeer","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.01.049_bib8","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2009.01.049_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1405.012","article-title":"Response to therapy in myasthenia gravis with anti-MuSK antibodies","volume":"1132","author":"Evoli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2009.01.049_bib10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2009.01.049_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0035-3787(04)70886-3","article-title":"Seronegative myasthenia gravis","volume":"160","author":"Gajdos","year":"2004","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2009.01.049_bib12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/mus.20479","article-title":"Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab","volume":"33","author":"Hain","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2009.01.049_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2009.01.049_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1749-6632.1987.tb51321.x","article-title":"Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis","volume":"505","author":"Howard","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2009.01.049_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneuroim.2008.04.039","article-title":"Sustained response to Rituximab in anti-AchR and anti-MuSK positive Myasthenia Gravis patients","volume":"201-202","author":"Illa","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2009.01.049_bib16","first-page":"68","article-title":"Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients","volume":"89","author":"Jitpimolmard","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.neurol.2009.01.049_bib17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1468-1331.2008.02176.x","volume":"15","author":"Kostera-Pruszczyk","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2009.01.049_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0404.2006.00721.x","article-title":"Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles","volume":"115","author":"Kuwabara","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2009.01.049_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.01.049_bib20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/jnnp.2004.052415","article-title":"The features of myasthenia gravis with autoantibodies to MuSK","volume":"76","author":"Lavrnic","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.01.049_bib21","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.01.049_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jocn.2005.04.028","article-title":"MuSK antibody-positive, seronegative myasthenia gravis in Korea","volume":"13","author":"Lee","year":"2006","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.neurol.2009.01.049_bib23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2009.01.049_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mus.20411","article-title":"High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies","volume":"33","author":"Lin","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2009.01.049_bib25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2009.01.049_bib26","first-page":"356","article-title":"Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report","volume":"47","author":"Nakahama","year":"2007","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.neurol.2009.01.049_bib27","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/jnnp.2004.043125","article-title":"Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis","volume":"76","author":"Nemoto","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.01.049_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jnnp.2006.102517","article-title":"Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in the Netherlands","volume":"78","author":"Niks","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.01.049_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.20498","article-title":"Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis","volume":"33","author":"Oh","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2009.01.049_bib30","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2007.01870.x","article-title":"Clinical and experimental features of MuSK antibody positive MG in Japan","volume":"14","author":"Ohta","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2009.01.049_bib31","first-page":"496","article-title":"A case of anti-MuSK antibody-positive myasthenia gravis with dropped head as the initial presenting symptom","volume":"46","author":"Okano","year":"2006","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.neurol.2009.01.049_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-1331.2006.01214.x","article-title":"Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK\u2212 patients","volume":"13","author":"Padua","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2009.01.049_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1468-1331.2005.01137.x","article-title":"Seronegative myasthenia gravis: disease severity and prognosis","volume":"12","author":"Romi","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2009.01.049_bib34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.clinph.2006.03.028","article-title":"Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes","volume":"117","author":"Rostedt Punga","year":"2006","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2009.01.049_bib35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1212\/WNL.65.5.782","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"65","author":"Saka","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.01.049_bib36","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.01.049_bib37","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/01.LAB.0000028144.48023.9B","article-title":"Anti-p110 autoantibodies identify a subtype of \u201cseronegative\u201d myasthenia gravis with prominent oculobulbar involvement","volume":"82","author":"Scuderi","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.neurol.2009.01.049_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1405.002","article-title":"Myasthenia gravis experimentally induced with muscle-specific kinase","volume":"1132","author":"Shigemoto","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2009.01.049_bib39","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.clinph.2005.06.003","article-title":"MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns","volume":"116","author":"Stickler","year":"2005","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2009.01.049_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-006-0442-2","article-title":"Rituximab in refractory MuSK antibody myasthenia gravis","author":"Thakre","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2009.01.049_bib41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0896-6273(95)90146-9","article-title":"Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury","volume":"15","author":"Valenzuela","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2009.01.049_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1474-4422(03)00306-5","article-title":"Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets","volume":"2","author":"Vincent","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2009.01.049_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.wco.0000180660.57801.3f","article-title":"Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis","volume":"18","author":"Vincent","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2009.01.049_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2009.01.049_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1196\/annals.1405.005","article-title":"Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive Myasthenia gravis","volume":"1132","author":"Wolfe","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2009.01.049_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jns.2007.05.033","article-title":"MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis","volume":"263","author":"Yeh","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2009.01.049_bib47","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1212\/01.WNL.0000128042.28877.C3","article-title":"Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese","volume":"62","author":"Yeh","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.01.049_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.20069","article-title":"Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients","volume":"30","author":"Zhou","year":"2004","journal-title":"Muscle Nerve"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378709001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378709001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T21:20:29Z","timestamp":1545340829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378709001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0035378709001507"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2009.01.049","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}